MRI, Enhanced CT, and FDG PET/CT in Basal Cell Carcinoma of the Prostate

被引：1
|
作者：
Dong, Aisheng [1 ]
Zuo, Changjing [1 ]
Lu, Jianping [2 ]
Wang, Yang [3 ]
机构：
[1] Second Mil Med Univ, Changhai Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China
[2] Second Mil Med Univ, Changhai Hosp, Dept Radiol, Shanghai 200433, Peoples R China
[3] Second Mil Med Univ, Changhai Hosp, Dept Pathol, Shanghai 200433, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2014年 / 39卷 / 08期
关键词：
basal cell carcinoma; prostate cancer; prostate; MRI; CT; FDG; PET/CT;
D O I：
10.1097/RLU.0000000000000280
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Primary basal cell carcinoma of the prostate is a very rare neoplasm with a good prognosis. A 55-year-old man presented with urinary frequency for 2 months. Serum prostate-specific antigen level was normal. T2-weighted MR images showed an inhomogeneously hyperintense tumor in the prostate. Enhanced CT showed heterogeneous enhancement of the tumor. FDG PET/CT showed strong FDG uptake of the tumor with SUVmax of 14.1. Prostate biopsy findings revealed basal cell carcinoma with high proliferation index.
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [1] Malignant Nonepithelial Prostate Tumors FDG PET/CT Findings With MRI and CT Correlation
    Dong, Aisheng
    Zhang, Huojun
    Wang, Yang
    Gong, Jing
    Zuo, Changjing
    Yang, Jijin
    Lu, Jianping
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (01) : 14 - 20
  • [2] Squamous Cell Carcinoma of the Prostate With Strong FDG Uptake on PET/CT
    Dong, Aisheng
    Zuo, Changjing
    Lu, Jianping
    Wang, Yang
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (07) : 650 - 652
  • [3] MRI and FDG PET/CT Findings of Malignant Fibrous Histiocytoma of the Prostate
    Dong, Aisheng
    Gong, Jing
    Wang, Yang
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (10) : 889 - 891
  • [4] Widespread Metastases in Small Cell Carcinoma of the Prostate on FDG PET/CT
    Yilmaz, Mustafa
    Celen, Zeki
    Sevinc, Alper
    Karakok, Metin
    CLINICAL NUCLEAR MEDICINE, 2009, 34 (09) : 598 - 600
  • [5] 18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
    Thacker, Curtis A.
    Weiss, Glen J.
    Tibes, Raoul
    Blaydorn, Lisa
    Downhour, Molly
    White, Erica
    Baldwin, Jason
    Von Hoff, Daniel D.
    Korn, Ronald L.
    CANCER MEDICINE, 2012, 1 (02): : 230 - 236
  • [6] A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell Carcinoma
    Huang, Shu-Hua
    Chien, Chi-Yen
    Lin, Wei-Che
    Fang, Fu-Min
    Wang, Pei-Wen
    Lui, Chun-Chung
    Huang, Yung-Cheng
    Hung, Bor-Tau
    Tu, Min-Chien
    Chang, Chiung-Chih
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (07) : 518 - 525
  • [7] Enhanced CT and FDG PET/CT Findings of Splenic Hamartoma
    Dong, Aisheng
    Wang, Yang
    Lu, Jianping
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (11) : 968 - 971
  • [8] Spectrum of the prostate lesions with increased FDG uptake on 18F-FDG PET/CT
    Dong, Aisheng
    Bai, Yushu
    Wang, Yang
    Zuo, Changjing
    Lu, Jianping
    ABDOMINAL IMAGING, 2014, 39 (04): : 908 - 921
  • [9] Assessment of pancreatic colloid carcinoma using 18F-FDG PET/CT compared with MRI and enhanced CT
    Jiang, Lei
    Tang, Qiying
    Panje, Cedric M.
    Nie, Hongting
    Zhao, Guochao
    Shi, Hongcheng
    ONCOLOGY LETTERS, 2018, 16 (02) : 1557 - 1564
  • [10] High-grade urothelial carcinoma of the prostate on FDG PET-CT
    Ho, Linh
    Quan, Vicki
    Henderson, Robert
    Seto, John
    CLINICAL NUCLEAR MEDICINE, 2007, 32 (09) : 746 - 747
12345